首页> 外文期刊>Orthopedic Research and Reviews >Update on the management of Dupuytren’s contracture
【24h】

Update on the management of Dupuytren’s contracture

机译:Dupuytren挛缩症的管理最新情况

获取原文
       

摘要

Abstract: Dupuytren’s disease (DD) is a pathological condition of the palmar fascia that is characterized by the formation of tight collagenous disease cords leading to permanent finger contractures. The disease is most prevalent in Caucasian men, and its incidence increases with age advancement. The most common complaint from patients having DD is the impairment of normal hand function. At present, the disease is incurable and the pathophysiology of DD is unknown. The most common treatment for DD is surgery; however, this treatment is associated with a high rate of recurrence. More recently, researchers have begun to explore the molecular basis of DD in the hopes of developing new, more effective treatment for DD. This review will summarize the history and clinical presentation of the disease, highlight current and emerging molecular treatments, and explore the implications of these advancements for future work.
机译:摘要:Dupuytren病(DD)是手掌筋膜的一种病理性疾病,其特征是形成紧密的胶原蛋白疾病索,导致手指永久性挛缩。该病在白人男性中最为普遍,并且其发病率随着年龄的增长而增加。患有DD的患者最常抱怨的是正常手功能的损害。目前,该病是无法治愈的,DD的病理生理尚不清楚。 DD最常见的治疗方法是手术。然而,这种治疗与高复发率有关。最近,研究人员开始探索DD的分子基础,希望为DD开发新的,更有效的治疗方法。这篇综述将总结该病的历史和临床表现,重点介绍当前和新兴的分子治疗方法,并探讨这些进展对未来工作的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号